Viewing Study NCT00500266



Ignite Creation Date: 2024-05-05 @ 6:34 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00500266
Status: COMPLETED
Last Update Posted: 2011-09-16
First Post: 2007-07-09

Brief Title: Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects
Sponsor: Pfizer
Organization: Pfizer

Study Overview

Official Title: A Phase 3 Open-Label Single-Arm Trial Evaluating the Safety Tolerability Reactogenicity of a 13vPnC Vaccine in Ambulatory Elderly Adults Aged 68 Years Older Who Received 1 or More Doses of 23vPS Vaccine at Least 3 Years Before Study Enrollment
Status: COMPLETED
Status Verified Date: 2011-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the safety of 13-valent pneumococcal conjugate vaccine 13vPnC in elderly subjects who were vaccinated with one or more doses of 23-valent pneumococcal polysaccharide vaccine 23vPS at least 3 years before study enrollment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None